Global Esoteric Testing Market Research 2024, Forecast To 2033
8 Mar, 2024
Esoteric testing market rose from $29.24 billion in 2023 to $32.73 billion in 2024, with a CAGR of 11.9%. Expected to hit $51.62 billion by 2028, growing at a CAGR of 12.1%. Demand for early disease detection and genomic research will drive growth, with trends like liquid biopsies and AI integration shaping the market.
Global Esoteric Testing Market Key Driver
The increasing prevalence of infectious diseases is expected to drive the growth of the esoteric testing market. Esoteric testing provides more accurate results for detecting infectious agents, with the number of malaria cases increasing globally. For instance, in 2021, 247 million people suffered from malaria, an increase from the previous year.
Get A Free Sample Of The Global Esoteric Testing Market ReportGlobal Esoteric Testing Market Segments
The esoteric testing market covered in this report is segmented –
1) Type:Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetics Testing, Toxicology Testing, Immunology Testing, Neurology Testing, Other Testing
2) Technology:Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Real-Time PCR, DNA (Deoxyribonucleic Acid) Sequencing, Flow Cytometry, Other Technologies
3) End User:Independent And Reference Laboratories, Hospital-Based Laboratories
By Geography: The countries covered in the esoteric testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the esoteric testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the esoteric testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Esoteric Testing Industry Players
LabCorp Holdings; Quest Diagnostics Inc.; Eurofins Scientific SE; Sonic Healthcare Limited; Miraca Holdings Inc.; H.U. Group Holdings Inc.; Arup Laboratories Inc.; OPKO Health Inc.; Mayo Medical Laboratories; SYNLAB International GmbH; Myriad Genetics Inc.; Bio-Reference Laboratories Inc.; NeoGenomics Laboratories; Foundation Medicine Inc.; Health Network Laboratories; Fulgent Genetics Inc.; Grifols S.A.; Adaptive Biotechnologies Corporation; Genova Diagnostics; Kind star Globalgene Technology Inc.; National Medical Services Inc. (NMS); ACM Global Laboratories LLC; Miraca Life Sciences Inc.; Leo Labs Inc.; Pacific Bio labs Inc.; Lab21 Healthcare Ltd.; HealthQuest Esoterics Inc.; Georgia Esoteric And Molecular Laboratory LLC.; Atherotech Diagnostics Lab; Spectra Laboratories Inc
Get The Full Global Esoteric Testing Market Report
Esoteric Testing Market Overview
Esoteric testing refers to the laboratory analysis of rare molecules and substances not typically studied in a routine clinical laboratory. This testing is used to diagnose and manage rare, complex, or unusual medical conditions that cannot be easily diagnosed through standard laboratory tests.